| V08B |
V08B X-Ray Contrast Media, Non-Iodinated |
| V08BA |
V08BA Barium sulfate containing X-ray contrast media |
| V08BA01 |
V08BA01 barium sulfate with suspending agents |
| V08BA02 |
V08BA02 barium sulfate without suspending agents |
| V08C |
V08C Magnetic resonance imaging contrast media |
| V08CA |
V08CA Paramagnetic contrast media |
| V08CA01 |
V08CA01 gadopentetic acid |
| V08CA02 |
V08CA02 gadoteric acid |
| V08CA03 |
V08CA03 gadodiamide |
| V08CA04 |
V08CA04 gadoteridol |
| V08CA05 |
V08CA05 mangafodipir |
| V08CA06 |
V08CA06 Gadoversetamide |
| V08CA07 |
V08CA07 ferric ammonium citrate |
| V08CA08 |
V08CA08 gadobenic acid |
| V08CA09 |
V08CA09 gadobutrol |
| V08CA10 |
V08CA10 gadoxetic acid |
| V08CA11 |
V08CA11 gadofosveset |
| V08CB |
V08CB Superparamagnetic contrast media |
| V08CB01 |
V08CB01 ferumoxsil |
| V08CB02 |
V08CB02 ferristene |
| V08CB03 |
V08CB03 iron oxide, nanoparticles |
| V08CX |
V08CX Other Magnetic Resonance Imaging Contrast Media |
| V08CX01 |
V08CX01 perflubron |
| V08D |
V08D Ultrasound contrast media |
| V08DA |
V08DA Ultrasound contrast media |
| V08DA01 |
V08DA01 microspheres of human albumin |
| V08DA02 |
V08DA02 microparticles of galactose |
| V08DA03 |
V08DA03 perflenapent |
| V08DA04 |
V08DA04 microspheres of phospholipids |
| V08DA05 |
V08DA05 sulfur hexafluoride |